Skip to main content
Login
Contact
Subscribe
Search form
Search
The Observer News Enterprise
Home
Forms
News
Sports
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Classifieds
Photos
Videos
Games
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Aldeyra Therapeu
(NQ:
ALDX
)
13.37
USD
+1.18 (+9.68%)
Official Closing Price
Updated: 6:55 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Aldeyra Therapeu
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
3 Biotech Stocks That Jumped Last Week
Today 9:59 EST
Find out what led to the biotech industry's biggest gains.
Tags
ALDX
LXRX
NCNA
From
Motley Fool
Notable Insider Buys Of The Past Week: Conagra Brands Plus Plenty Of Biotech Activity
January 16, 2021
Insider buying can be an encouraging signal for investors, particularly when there is uncertainty in the markets, as there has been due to the pandemic and political issues. Here are some insider...
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Notable Insider Buys Of The Past Week: Conagra Brands Plus Plenty Of Biotech Activity
January 16, 2021
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Insiders were taking ...
Tags
YORW
Aldeyra Therapeutics
REV Group
From
Benzinga
Stocks That Hit 52-Week Highs On Friday
January 15, 2021
This morning 150 companies reached new 52-week highs. Interesting Points: Eli Lilly (NYSE:LLY) was the largest firm ...
Tags
REKR
GRNV
News
From
Benzinga
70 Biggest Movers From Yesterday
January 15, 2021
Gainers Poshmark, Inc. (NASDAQ: POSH) shares climbed 141.7% to close at $101.50 on Thursday as the company priced its IPO at $42 ...
Tags
NPA
BNR
Markets
From
Benzinga
Why Aldeyra Therapeutics Stock Is Jumping Today
January 14, 2021
The company announced the pricing of a public stock offering.
Tags
Market News
ALDX
From
Motley Fool
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
January 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Market News
KOD
BCAB
From
Benzinga
Aldeyra Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
January 13, 2021
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with...
From
Business Wire News Releases
Aldeyra Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
January 13, 2021
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with...
From
Business Wire News Releases
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
January 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
FUSN
BHC
IBB
From
Benzinga
Thinking about buying stock in T2 Biosystems, Zomedica, Aldeyra Therapeutics, La Jolla Pharmaceutical, or US Well Services?
January 12, 2021
InvestorsObserver issues critical PriceWatch Alerts for TTOO, ZOM, ALDX, LJPC, and USWS.
From
PR Newswire
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
January 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
JNJ
MRK
EYEN
From
Benzinga
82 Biggest Movers From Friday
January 11, 2021
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 177% to close at $2.13on Friday after the company announced ...
Tags
MRUS
BRPA
NM
From
Benzinga
Aldeyra Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BioConnect 2021 Virtual Conference
January 08, 2021
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright...
From
Business Wire News Releases
95 Biggest Movers From Yesterday
January 08, 2021
Gainers Future FinTech Group Inc. (NASDAQ: FTFT) shares climbed 242.3% to close at $5.75 on Thursday as the company said China ...
Tags
Movers
NCTY
MTLS
From
Benzinga
The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration
January 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
SGMO
MOR
Small Cap
From
Benzinga
Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY Trial in Dry Eye Disease
January 07, 2021
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced positive top-line symptom, redness, and Schirmer’s test results from the run-in cohort of the Phase 3 TRANQUILITY clinical trial in...
From
Business Wire News Releases
Aldeyra Therapeutics to Host Conference Call and Webcast to Discuss Top-Line Symptom, Redness, and Schirmer’s Test Results from Run-in Cohort of Phase 3 TRANQUILITY Trial
January 06, 2021
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call and webcast at 8:00 a.m. ET Thursday, January 7, 2021, to discuss top-line symptom, redness, and Schirmer’s test results...
From
Business Wire News Releases
Aldeyra Therapeutics Announces Confirmation of Antiviral Activity of ADX-1612
December 22, 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced confirmation of SARS-CoV-2 antiviral activity of ADX-1612, in addition to novel anti-inflammatory activity in SARS-CoV-2-infected...
From
Business Wire News Releases
Aldeyra Therapeutics Announces Initiation of Phase 2 Clinical Trials of ADX-629, a First-in-Class Orally Administered RASP Inhibitor, for the Treatment of COVID-19, Atopic Asthma, and Psoriasis
December 17, 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced the initiation of Phase 2 clinical trials of ADX-629, a first-in-class orally administered reactive aldehyde species (RASP)...
From
Business Wire News Releases
Benzinga's Top Upgrades, Downgrades For December 16, 2020
December 16, 2020
Upgrades For Amplify Energy Corp (NYSE: AMPY), Roth Capital upgraded the previous rating of Neutral to the current rating Buy. For ...
Tags
SAVE
HAIN
PANW
From
Benzinga
Analysts Forecast 15% Gains Ahead For The Holdings of PTH
December 14, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Aldeyra Announces First Patient Enrolled in the Phase 3 TRANQUILITY Trial of Reproxalap for the Treatment of Dry Eye Disease
December 08, 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with...
From
Business Wire News Releases
Aldeyra Therapeutics to Participate in the Jefferies and A.G.P./Alliance Global Partners Virtual Investor Conferences
November 13, 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the company’s senior management will participate in the following virtual investor conferences:
From
Business Wire News Releases
The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap
November 11, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Benzinga
OCUL
ORIC
From
Benzinga
How The Parts Add Up: DWAS Headed For $75
November 10, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
November 08, 2020
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ...
Tags
NKTR
PRAX
ATHX
From
Benzinga
Aldeyra Therapeutics Announces Third-Quarter 2020 Financial Results and Provides Corporate Update
November 05, 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with...
From
Business Wire News Releases
Aldeyra to Participate in the American Academy of Ophthalmology Eyecelerator 2020 Virtual Conference on Friday, November 6
November 04, 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that President and CEO Todd C. Brady, M.D., Ph.D., will discuss Aldeyra’s novel therapeutic approaches to treating anterior and...
From
Business Wire News Releases
Aldeyra Has 'Catalayst-Rich' 12 Months Ahead, Jefferies Says In Bullish Initiation
October 30, 2020
Shares of Aldeyra Therapeutics Inc (NASDAQ: ALDX), a company focusing on immune-mediated diseases, are primed for further upside, ...
Tags
Analyst Ratings
Analyst Color
Kelly Shi
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.